Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
Accesswire
*The drug candidate demonstrates antipsychotic activity and has a mechanism of action distinct from FDA-approved therapies for..
